Cibus (CBUS) Cost of Revenue (2016 - 2021)
Cibus (CBUS) posted Cost of Revenue of $2.0 million for Q4 2021, down 75.8% sequentially from $8.3 million in Q3 2021, and down 89.38% YoY from $18.9 million in Q4 2020.
Cibus (CBUS) Cost of Revenue (2016 - 2021) Analysis & Trends
Cibus has reported Cost of Revenue for 4 years, with the latest figure at $2.0 million in Q4 2021.
- Quarterly Cost of Revenue fell 89.38% year-over-year to $2.0 million in Q4 2021, while the trailing twelve-month figure through Sep 2022 was $2.0 million (down 95.59% YoY) and the FY2021 annual result came in at $28.6 million, down 18.7% from the prior year.
- Cost of Revenue eased to $2.0 million in Q4 2021 per CBUS's latest filing, from $8.3 million in the prior quarter.
- Over five years, Cost of Revenue peaked at $18.9 million in Q4 2020 and troughed at $34000.0 in Q1 2019.
- A 3-year average of $6.1 million and a median of $5.4 million in 2019 frame the typical range for Cost of Revenue.
- The sharpest annual moves came in 2020 and 2021: Cost of Revenue surged 11323.53% in 2020, then tumbled 89.38% in 2021.
- Over 3 years, Cost of Revenue stood at $5.4 million in 2019, then soared by 248.33% to $18.9 million in 2020, then sank by 89.38% to $2.0 million in 2021.
- According to Business Quant data, Cost of Revenue over the past three periods registered $2.0 million, $8.3 million, and $11.5 million for Q4 2021, Q3 2021, and Q2 2021 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 489.20 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 360.70 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 145.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 93.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 174.53 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 298.26 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 67.21 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 387.98 Mn |
| 10 | Cibus | 131.25 Mn | 110.82 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 2.00 Mn |
| Dec 31, 2021 | 2.00 Mn |
| Sep 30, 2021 | 8.28 Mn |
| Sep 30, 2021 | 8.28 Mn |
| Jun 30, 2021 | 11.53 Mn |
| Jun 30, 2021 | 11.53 Mn |
| Mar 31, 2021 | 6.75 Mn |
| Mar 31, 2021 | 6.75 Mn |
| Dec 31, 2020 | 18.86 Mn |
| Dec 31, 2020 | 18.86 Mn |
| Sep 30, 2020 | 7.06 Mn |
| Sep 30, 2020 | 7.06 Mn |
| Jun 30, 2020 | 5.32 Mn |
| Jun 30, 2020 | 5.32 Mn |
| Mar 31, 2020 | 3.88 Mn |
| Mar 31, 2020 | 3.88 Mn |
| Dec 31, 2019 | 5.42 Mn |
| Dec 31, 2019 | 5.42 Mn |
| Sep 30, 2019 | 3.53 Mn |
| Sep 30, 2019 | 3.53 Mn |